Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteaxeriontherapeuti...
CategoryBioTech
Phone203-492-0550
Emailinfo@AxerionThera...
Employees

Offices

New Haven, USA
555 Long Wharf Drive
11th Floor
New Haven, CT, 06511
USA

People

Chairman of the Board
President and CEO
Board of Directors

Funding

TOTAL $1.15M
FUNDING TOTAL $1.15M
Seed, 4/2010
Connecticut Innovations
$750k
Venture Round, 10/2011
Connecticut Innovations
$400k

Tags

Axerion Therapeutics

Axerion Therapeutics, Inc. is a private Connecticut-based biotechnology company focused on developing innovative therapeutics for neurological diseases and injuries with significant unmet medical need, including Alzheimer’s disease and spinal cord injury.

Axerion was established in New Haven to develop and commercialize intellectual property licensed from Dr. Stephen Strittmatter’s laboratory at Yale University. Axerion’s proprietary technology platforms include blockers of ß-amyloid (Aß) oligomers binding to Prion Proteins (PrP) on the cell surface of neurons as a novel therapeutic target for Alzheimer’s disease and Nogo Receptor decoy protein for recovery of neurological function in spinal cord injury and other neurological diseases.

Recent Milestones

Videos

Screenshots

Sources

  1. Connecticut Innovations Makes $750,000 Investment in Axerion Therapeutics, Inc. (ctinnovations.com) [edit]
  2. Conn. therapeutics startup Axerion scores more CI investments (masshightech.com) [edit]
Edit This Page
Last Edited 12/20/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy